Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine in Children With Autism
NCT00873834Phase 2Withdrawn
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of fluoxetine in Autism Spectrum Disorder (ASD), sponsored by Assistance publique - Hôpitaux de Paris. Planned start Sep 2009; status: withdrawn.
02
Drugs
fluoxetine
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT00873834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00873834.